Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
Authors
Keywords
-
Journal
eLife
Volume 10, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2021-06-14
DOI
10.7554/elife.62927
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
- (2021) Song Wang et al. Journal of Translational Medicine
- Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway
- (2020) Jeoung-Eun Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
- (2020) David H. Peng et al. Nature Communications
- Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
- (2020) Simona Sivori et al. Frontiers in Immunology
- Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade
- (2020) Christina Jensen et al. Cancers
- Collagen density regulates the activity of tumor-infiltrating T cells
- (2019) Dorota E. Kuczek et al. Journal for ImmunoTherapy of Cancer
- Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
- (2019) Neel I. Nissen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of collagen in cancer: from bench to bedside
- (2019) Shuaishuai Xu et al. Journal of Translational Medicine
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- High expression of COL10A1 is associated with poor prognosis in colorectal cancer
- (2018) Haipeng Huang et al. OncoTargets and Therapy
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
- (2018) Grégory Ehx et al. Frontiers in Immunology
- Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
- (2018) Christina Jensen et al. Journal for ImmunoTherapy of Cancer
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
- (2016) Roberta Bulla et al. Nature Communications
- Neutrophils, Wounds, and Cancer Progression
- (2015) Emily E. Rosowski et al. DEVELOPMENTAL CELL
- The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer
- (2015) N. Antonio et al. EMBO JOURNAL
- Overexpression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer
- (2015) Zunfu Ke et al. Oncotarget
- Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
- (2014) Alexandra Naba et al. BMC CANCER
- Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer
- (2014) N. Hartmann et al. CLINICAL CANCER RESEARCH
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Connecting Fibrosis and Solid Tumor Metastasis
- (2014) T. R. Cox et al. CLINICAL CANCER RESEARCH
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- Granzyme B Promotes Cytotoxic Lymphocyte Transmigration via Basement Membrane Remodeling
- (2014) Monica D. Prakash et al. IMMUNITY
- The Soluble Leukocyte-Associated Ig-Like Receptor (LAIR)-2 Antagonizes the Collagen/LAIR-1 Inhibitory Immune Interaction
- (2014) R. J. Lebbink et al. JOURNAL OF IMMUNOLOGY
- Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D
- (2014) Marloes J. M. Olde Nordkamp et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line
- (2014) Radosław Januchowski et al. Biomed Research International
- Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
- (2014) Alexandra Naba et al. eLife
- Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets
- (2013) Xiao Xu et al. BMC BIOINFORMATICS
- The role of LAIR-1 (CD305) in T cells and monocytes/macrophages in patients with rheumatoid arthritis
- (2013) Y. Zhang et al. CELLULAR IMMUNOLOGY
- A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
- (2013) Dong-Joo Cheon et al. CLINICAL CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Inhibition of the Classical and Lectin Pathway of the Complement System by Recombinant LAIR-2
- (2013) Marloes J.M. Olde Nordkamp et al. Journal of Innate Immunity
- COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer
- (2013) Y-H Wu et al. ONCOGENE
- Serum LAIR-2 Is Increased in Autoimmune Thyroid Diseases
- (2013) Rita Simone et al. PLoS One
- Collagen as a double-edged sword in tumor progression
- (2013) Min Fang et al. TUMOR BIOLOGY
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
- (2012) Hélène Salmon et al. JOURNAL OF CLINICAL INVESTIGATION
- Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype
- (2012) Niwa Ali et al. PLoS One
- C1q limits dendritic cell differentiation and activation by engaging LAIR-1
- (2012) M. Son et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1
- (2011) Marloes J. M. Olde Nordkamp et al. ARTHRITIS AND RHEUMATISM
- The Matrisome:In SilicoDefinition andIn VivoCharacterization by Proteomics of Normal and Tumor Extracellular Matrices
- (2011) Alexandra Naba et al. MOLECULAR & CELLULAR PROTEOMICS
- Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1
- (2011) Tomasz P. Rygiel et al. MOLECULAR IMMUNOLOGY
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- The Extracellular Matrix: Not Just Pretty Fibrils
- (2009) R. O. Hynes SCIENCE
- Structural characterization of a human Fc fragment engineered for lack of effector functions
- (2008) Vaheh Oganesyan et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now